--- title: Recent Posts (12) description: (12) --- - [Our Customers and Partners](http://www.congenica.com/our-customers) - [Our Product Portfolio](http://www.congenica.com/congenica-products) - **Inherited Diseases** - [Rare Disease](http://www.congenica.com/congenica-rare-disease) - [Inherited Cancer](http://www.congenica.com/congenica-inherited-cancer) - [Prenatal Health](http://www.congenica.com/congenica-prenatal) - [Carrier Screening](http://www.congenica.com/congenica-carrier-screening) - [Neurodevelopmental Disorders](http://www.congenica.com/congenica-neuro) - **Somatic Oncology** - [Solid Tumours](http://www.congenica.com/congenica-oncology) - **Pathogen** - [Pathogen Surveillance](http://www.congenica.com/congenica-pathogen-surveillance) - [Our Services](http://www.congenica.com/congenica-services) - [Clinical Interpretation Services](http://www.congenica.com/congenica-clinical-interpretation-services) - [Professional Services](http://www.congenica.com/professional-services) - [Customer Support](http://www.congenica.com/customer-support) - [Pharma Services](http://www.congenica.com/pharma-services) - Resources - [News](https://blog.congenica.com/) - [About us](http://www.congenica.com) - [Leadership Team](http://www.congenica.com/leadership) - [Quality](http://www.congenica.com/quality) - [Investors](http://www.congenica.com/investors) - [People and Vacancies](http://www.congenica.com/people) - [Contact us](http://www.congenica.com/contact) Login ##### Please select your location and reference genome: [America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/) # Latest News and Blogs ![Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification](https://blog.congenica.com/hs-fs/hubfs/Data%204_Light_Banner.jpg?width=320&height=192&name=Data%204_Light_Banner.jpg) 12/9/2020 #### [Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification](https://blog.congenica.com/overcoming-challenges-to-accelerate-variant-classification) As more cases undergo genomic testing and the global supply of classified genomic data increases, reducing repetitive work is essential to scaling access to genomic analysis. ![How to research COVID-19 host genetics?](https://blog.congenica.com/hs-fs/hubfs/covid_2_light_banner.jpg?width=320&height=192&name=covid_2_light_banner.jpg) 12/8/2020 #### [How to research COVID-19 host genetics?](https://blog.congenica.com/congenica-launches-new-host-genetics-module-to-advance-covid-19-research-0) Congenica’s COVID-19 host genetics analysis module, enables researchers to identify genes that influence COVID-19 susceptibility, progression and severity. ![Inclusion in AJHG “Year in Review” 2020](https://blog.congenica.com/hs-fs/hubfs/AJHG%20Year%20in%20Review.jpg?width=320&height=192&name=AJHG%20Year%20in%20Review.jpg) 12/7/2020 #### [Inclusion in AJHG “Year in Review” 2020](https://blog.congenica.com/inclusion-in-ajhg-year-in-review-2020) The American Journal of Human Genetics has published its Genomic Medicine Year in Review for 2020, which includes a study featuring Congenica. ![Charles’ Story](https://blog.congenica.com/hs-fs/hubfs/Imogen%20at%201%20hr%20old.jpg?width=320&height=192&name=Imogen%20at%201%20hr%20old.jpg) 12/4/2020 #### [Charles’ Story](https://blog.congenica.com/a-dual-perspective-on-genomic-medicine-0-0-0) Our daughter Imogen was born in 2012 at 30 weeks, and spent her first month in intensive care. ![The complexity of epilepsy - an overview](https://blog.congenica.com/hs-fs/hubfs/Charlie%20and%20family%20.png?width=320&height=192&name=Charlie%20and%20family%20.png) 12/1/2020 #### [The complexity of epilepsy - an overview](https://blog.congenica.com/a-dual-perspective-on-genomic-medicine-0-0) My name is Charles, and I'm both a Genome Scientist and the Patient Advocacy & Engagement Lead at Congenica, Cambridge, UK ![Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer](https://blog.congenica.com/hs-fs/hubfs/Muthu-transparent-bg-v2.png?width=320&height=192&name=Muthu-transparent-bg-v2.png) 12/1/2020 #### [Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer](https://blog.congenica.com/congenica-appoints-dr.-muthu-meyyappan-as-chief-commercial-officer) Dr. Muthu Meyyappan appointed Chief Commercial Officer (CCO), of Congenica. Based in Boston, MA, Muthu will lead Congenica’s global market expansion. ![Congenica Appoints Dr. Sam Roberts as Non-Executive Director](https://blog.congenica.com/hs-fs/hubfs/Sam%20Roberts%20picture.jpg?width=320&height=192&name=Sam%20Roberts%20picture.jpg) 11/20/2020 #### [Congenica Appoints Dr. Sam Roberts as Non-Executive Director](https://blog.congenica.com/congenica-appoints-dr-sam-roberts-as-non-executive-director) Congenica appoints Dr. Sam Roberts as Non-Executive Director to the Board. Sam is the Managing Director of Health & Care at Legal & General. ![Inherited Disorders: Bioinformatic Analysis that Surpasses All Others](https://blog.congenica.com/hs-fs/hubfs/social-suggested-images/genomics.congenica.comhubfsClinicians-1-13.png?width=320&height=192&name=genomics.congenica.comhubfsClinicians-1-13.png) 11/17/2020 #### [Inherited Disorders: Bioinformatic Analysis that Surpasses All Others](https://blog.congenica.com/inherited-disorders-new-study-highlights-bioinformatic-analysis) A recent study has shown that the Congenica platform demonstrated a superior role identifying the genetic causes of platelet-related bleeding disorders ![Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform](https://blog.congenica.com/hs-fs/hubfs/social-suggested-images/genomics.congenica.comhubfsBaby%20on%20shoulder-7.jpg?width=320&height=192&name=genomics.congenica.comhubfsBaby%20on%20shoulder-7.jpg) 11/9/2020 #### [Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform](https://blog.congenica.com/congenica-completes-50m-series-c-funding-round-to-advance-clinical-genomic-analysis-software-and-data-platform) New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations ![Our plans for the future: a video message from our CEO and Chairman](https://blog.congenica.com/hs-fs/hubfs/Screenshot%202020-11-08%20at%2011.51.07.png?width=320&height=192&name=Screenshot%202020-11-08%20at%2011.51.07.png) 11/9/2020 #### [Our plans for the future: a video message from our CEO and Chairman](https://blog.congenica.com/our-plans-for-the-future-a-video-message-from-our-ceo-and-chairman) Congenica CEO David Atkins PhD is joined by Chairman Andy Richards OBE in announcing the company's Series C fundraise. ![The culture changes needed to mainstream genomics](https://blog.congenica.com/hs-fs/hubfs/social-suggested-images/genomics.congenica.comhubfsWoman%20Looking%20into%20Distance-9.jpg?width=320&height=192&name=genomics.congenica.comhubfsWoman%20Looking%20into%20Distance-9.jpg) 10/26/2020 #### [The culture changes needed to mainstream genomics](https://blog.congenica.com/the-culture-changes-needed-to-mainstream-genomics) We spoke to a number of industry leaders to discuss their thoughts on the culture changes needed to mainstream genomics. ![The importance of improving the efficiency of genetic analysis](https://blog.congenica.com/hs-fs/hubfs/Sequence%20Data_2.jpg?width=320&height=192&name=Sequence%20Data_2.jpg) 10/19/2020 #### [The importance of improving the efficiency of genetic analysis](https://blog.congenica.com/the-importance-of-improving-the-efficiency-of-genetic-analysis) We spoke to a number of industry leaders to find out their thoughts on the importance of improving the efficiency of genetic analysis. ##### Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory. - [Privacy Policy](http://www.congenica.com/privacy-policy) - [Cookie Policy](http://www.congenica.com/cookie-policy) Log in to Congenica ##### Please select your location and reference genome: [America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/) ![CE](https://blog.congenica.com/hs-fs/hubfs/CE.png?width=80&height=80&name=CE.png) ![ISO-27001](https://blog.congenica.com/hs-fs/hubfs/ISO-27001.jpg?width=80&height=80&name=ISO-27001.jpg) ![TR-Testmark\_9000030872\_EN\_2024\_CMYK](https://blog.congenica.com/hs-fs/hubfs/2023%20website%20images/TR-Testmark_9000030872_EN_2024_CMYK.png?width=80&height=80&name=TR-Testmark_9000030872_EN_2024_CMYK.png) ![HIPAA Compliant](https://blog.congenica.com/hs-fs/hubfs/HIPAA%20Compliant.png?width=80&height=80&name=HIPAA%20Compliant.png) Copyright © 2026 Congenica Ltd. Company number: 8273616 Registered in England and Wales.